CrushSCI.com
85.9Average days
79Median days
20Fastest days
155Longest days
872025 publications

Paper Review Records

All Paper Review Records

27 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

40 days

Retrospective RNA Sequencing Reclassifies a Historical t (5;12) Eosinophilic Neoplasm From Presumed PDGFRB Rearrangement to ETV6::ACSL6

Authors
Frédéric Lambert; Rafael Fernandez Carazo; Benjamin Koopmansch; Elisa Dardenne; Pierre Sidon; Gaëlle Vertenoeil; Pierre HeimannShow moreShow less
Affiliations
1. Center for Human Genetics and Department of Laboratory Medicine University Hospital of Liège Liège Belgium; 2. Department of Laboratory Medicine, Cytogenetics Laboratory Free University of Brussels, LHUB‐ULB and Jules Bordet Institute Anderlecht Belgium; 3. Department of Hematology University Hospital of Liège Liège Belgium; 4. Department of Laboratory Medicine, Hematology Laboratory, Free University of Brussels LHUB‐ULB and Jules Bordet Institute Anderlecht BelgiumShow moreShow less
Source PDF DOI Publisher page
91 days

Tumor Profile, Clinical Features, and Outcomes in Individuals With Constitutional Trisomy 8: A Systematic Review of Case Reports and Case Series

Authors
Ehsan Taherifard; Alexandre Theron; Erfan Taherifard; Motoi Nishi; Michel Vekemans; Daniel SatgéShow moreShow less
Affiliations
1. Hematology Research Center Shiraz University of Medical Sciences Shiraz Iran; 2. Pediatric Hematology and Oncology Department Montpellier University Hospital Montpellier France; 3. Department of Fundamental Health Sciences Health Sciences University of Hokkaido Sapporo Japan; 4. Department of Human Genetics University of Paris Paris France; 5. Oncodéfi Montpellier France; 6. Desbrest Institute of Epidemiology and Public Health, INSERM University of Montpellier Montpellier FranceShow moreShow less
Source PDF DOI Publisher page
154 days

HPV ‐Associated Adenosquamous Carcinoma of the Oropharynx With a PARD3B :: ERBB4 Fusion

Authors
Seddig Momenkhan; Jacques Blanc; Pierre Philouze; Jonathan Lopez; Francoise Descotes; Eudeline Alix; Camille Leonce; Ziyad Alsugair; Nazim BenzerdjebShow moreShow less
Affiliations
1. Service d'Anatomie et cytologie pathologiques Institut de Pathologie Multisite, Hospices Civils de Lyon, CHU Lyon Sud Pierre‐Bénite France; 2. Faculty of Medicine King Abdulaziz University Jeddah Saudi Arabia; 3. Service d'Oto‐Rhino‐Laryngologie et Chirurgie Cervico‐Faciale Hôpital La Croix Rousse, Hospices Civils de Lyon Lyon France; 4. Service de Biochimie et Biologie Moléculaire, CHU Lyon Sud, Hospices Civils de Lyon Université Claude Bernard Lyon I Pierre‐Bénite France; 5. Service d’Anatomie et cytologie pathologiques, Institut de Pathologie Multisite Hospices Civils de Lyon, CHU Lyon Est Pierre‐Bénite France; 6. CICLY Pierre‐Bénite FranceShow moreShow less
Source PDF DOI Publisher page
124 days

IRF8 Suppresses Hepatocellular Carcinoma Progression Through LIAS ‐Dependent IFN Production and Cuproptosis Activation

Authors
Li Zhu; Zhaoxia Hu; Bei Wu; Meng Duan; Li Wang; Ruiqing Hu; Hongfan Liao; Xiaosi Zhao; Yilan Zeng; Lei Li; Yuelian Wang; Mei LuoShow moreShow less
Affiliations
1. Second Department of Hepatology Chengdu Public Health Clinical Center Chengdu People's Republic of China; 2. Xiamen AMOYTOP Biotech Co, Ltd. Xiamen People's Republic of China; 3. Department of Integrated Traditional Chinese and Western Medicine Chengdu Public Health Clinical Center Chengdu People's Republic of China; 4. Center for Precision and Translational Medicine Chengdu Public Health Clinical Center Chengdu People's Republic of ChinaShow moreShow less
Source PDF DOI Publisher page
71 days

Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia

Authors
Jun Nagai; Shota Yoshida; Takanori Teshima; Masahiro OnozawaShow moreShow less
Affiliations
1. Department of Hematology Hokkaido University Hospital Sapporo JapanShow moreShow less
Source PDF DOI Publisher page
107 days

NOTCH3 Internal Tandem Duplication Defines a Novel Oncogenic Activation Mechanism of NOTCH Signaling

Authors
Hongyi Gao; Si Chen; Ying Wu; Jintao Fu; Rongjun Mao; Mei Yang; Yanan Li; Zhiyue Bao; Huafei Chen; Jingjing Feng; Lijun Meng; Sheng XiaoShow moreShow less
Affiliations
1. Department of Pathology Guangdong Women and Children Hospital Guangzhou China; 2. Advanced Molecular Pathology Institute of Soochow University and SANO Suzhou China; 3. Suzhou SANO Precision Medicine Ltd, SANO Medical Laboratories Suzhou China; 4. Department of Pathology Foshan Hospital of Traditional Chinese Medicine Foshan China; 5. Department of Pathology The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine Foshan ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.